Stay updated with breaking news from Nasdaq Rapt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SVB Leerink cut shares of RAPT Therapeutics (NASDAQ:RAPT – Free Report) from an outperform rating to a market perform rating in a research report released on Wednesday, MarketBeat reports. SVB Leerink currently has $10.00 price objective on the stock, down from their previous price objective of $42.00. Several other research firms have also commented on […]
HC Wainwright downgraded shares of RAPT Therapeutics (NASDAQ:RAPT – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Wednesday morning, Marketbeat reports. Several other research firms have also recently commented on RAPT. JPMorgan Chase & Co. increased their target price on RAPT Therapeutics from $32.00 to […]
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven analysts that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average twelve-month price objective among […]
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eleven brokerages that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average twelve-month target price […]
Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) have earned an average recommendation of “Buy” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have updated their coverage on the stock in […]